Healthcare Professional Check

This website is intended for diabetes healthcare professionals. Click one of the options below to access the content.

You are here

Efficacy and Safety for Diabetes Specialists

The purpose of this course is to learn how the efficacy and safety of basal insulin–glucagon-like peptide-1 (GLP-1) receptor agonist combination therapy surpasses that of the individual components. Participants will learn how to identify patients who are most likely to benefit from this combination. Practical considerations will be discussed, including tips on how to best manage patients during treatment with basal insulin–GLP-1 receptor agonist combination therapy.

Now available